FDA Approved: IZERVAY — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for IZERVAY (avacincaptad pegol) submitted by Astellas Pharma US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• IZERVAY (avacincaptad pegol)

Snippet

SUPPL AP for IZERVAY (AVACINCAPTAD PEGOL)